Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comparative Study
. 1984 Jan;4(1):40-4.
doi: 10.1007/BF00915286.

Antibodies to a nuclear/nucleolar antigen in patients with polymyositis overlap syndromes

Comparative Study

Antibodies to a nuclear/nucleolar antigen in patients with polymyositis overlap syndromes

M Reichlin et al. J Clin Immunol. 1984 Jan.

Abstract

A precipitating antigen-antibody system has been characterized that occurs in patients with polymyositis. At least half of the patients not only have polymyositis but also have scleroderma. The proposed name for this antigen found in calf thymus extract (CTE) is PM-Scl, to indicate the almost universal presence of polymyositis and the frequent occurrence of scleroderma in the patients who make antibodies to this antigen. The antigen is probably nucleolar since all sera which precipitate with the PM-Scl antigen stain the nucleoli of Hep2 cells by indirect immunofluorescence. The PM-Scl immune system is a distinctive one different from the other known precipitins that occur in patients with polymyositis and dermatomyositis including Jo1, nRNP, and Mi. This PM-Scl antigen and its antibody represent one system which constitutes part of the reactions previously designated as PM1. Interlaboratory exchange of sera and extracts have established the unique nature of this reaction which occurs in patients with inflammatory myopathy.

PubMed Disclaimer

References

    1. N Engl J Med. 1975 Feb 13;292(7):344-7 - PubMed
    1. Arthritis Rheum. 1980 May;23(5):581-90 - PubMed
    1. Clin Immunol Immunopathol. 1976 Jan;5(1):12-20 - PubMed
    1. J Clin Invest. 1977 Jan;59(1):176-8 - PubMed
    1. Mol Immunol. 1980 Sep;17(9):1129-41 - PubMed

Publication types